Explode tree Collapse tree
GOZES / LEVINE
Neuroprotection in Autism, Schizophrenia and Alzheimer's disease
Offers an up-to-date overview of basic and clinical studies concerning similarities in the most prevalent brain disorders Helps the reader become familiar with novel neuroprotective mechanisms and experimental treatment modalities in these difficult to treat disordersWritten for researchers, clinicians and medical physicians in neuroscience, neurology and psychiatryTable of ContentsSection I. Overview1. Activity-dependent neuroprotective protein (ADNP)/NAP (CP201): autism, schizophrenia and Alzheimer’s disease2. Clinical convergence of autism, schizophrenia and Alzheimer’s disease: The case of social cognitionSection II. Autism3. A contemporary view on the molecular basis of neurodevelopmental disorders4. Autism spectrum disorder - A clinical path to early diagnosis, evaluation and intervention5. Neuro-inflammation and neuroprotection in schizophrenia and autism spectrum disorderSection III. Neuropsychiatric Disorders6. Neuroprotective roles of neurotrophic factors in depression7. Neuroprotective roles of neurotrophic growth factors in mood disorders8. Heme metabolism, mitochondria and complex I in neuropsychiatric disorders9. Neuroprotective effects of lithium in neuropsychiatric disordersSection IV. Alzheimer and Neurodegenerative Diseases10. Tau-based therapies for Alzheimer´s disease: promising novel neuroprotective approaches11. Acetylation of tubulin: a feasible protective target from neurodevelopment to neurodegeneration?
Print-on-Demand
